Combined with the last dividend raise by +3.3% in December 2024, building upon the 10Y growth profile at +5.27%, we believe ...

A look at the shareholders of Bristol-Myers Squibb Company (NYSE:BMY) can tell us which group is most powerful. With 81% ...

BMY stock offers value with a sub-7x P/E, 6% dividend yield, and strong earnings. Discover why it’s a compelling buy despite ...

After revealing in February plans to save $2 billion more on top of a previously disclosed cost-cutting initiative, Bristol Myers Squibb is conducting another round of job cuts in the Garden State.

Bristol Myers Squibb Co. (Symbol ... In general, dividends are not always predictable; but, looking at the history chart below can help in judging whether the most recent dividend is likely ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Bristol Myers BMY announced that the European Commission (EC) has approved the subcutaneous formulation of Opdivo (nivolumab) ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...